跳至主要内容
临床试验/NL-OMON51092
NL-OMON51092已完成4 期

The role of renal function in the pharmacokinetics and safety of remdesivir in COVID-19 patients - Remdesivir in renal impairment

HagaZiekenhuis0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - diagnosed with COVID-19 by polymerase chain reaction (PCR) on exudate
  • obtained by oral- nasopharyngeal swab
  • - admitted to the Haga hospital (ward or ICU)
  • - prescribed intravenous remdesivir
  • - The subject has signed and dated a written informed consent.

排除标准

  • - is expected to be transferred to another hospital during remdesivir therapy
  • - The treating physician deems the subject unfit to participate in this study.
  • - Pregnancy
  • - Patients who choose to forego dialysis and prefer to be managed
  • conservatively

研究者

相似试验